Kefir-derived exopolysaccharide ameliorates hyperglycemic control and beta cell integrity in a rat model of type 2 diabetes mellitus
Exopolysaccharides derived from kefir show promising potential in managing type 2 diabetes mellitus in rats, suggesting a viable nutraceutical therapy. Further research is needed to validate these findings in human subjects.
Authors
- Hsiao‐Ling Chen (ORCID: https://orcid.org/0000-0001-7544-2178)
- Chi‐Hua Ko
- Min‐Yu Tu (ORCID: https://orcid.org/0000-0003-2723-9372)
- Gary Ro‐Lin Chang
- Chih‐Ching Yen (ORCID: https://orcid.org/0000-0002-9355-7961)
- Chun‐Ming Tsai (ORCID: https://orcid.org/0000-0002-2462-637X)
- Chuan‐Mu Chen (ORCID: https://orcid.org/0000-0003-2461-9150)
- Ying‐Wei Lan (ORCID: https://orcid.org/0000-0001-6226-7382)
Institutions
- Dayeh University (TW)
- National Chung Hsing University (TW)
- National Quemoy University (TW)
- China Medical University (TW)
- Chang Gung Memorial Hospital (TW)
- Zuoying Armed Forces General Hospital (TW)
- Phoenix Children's Hospital (US)
- China Medical University Hospital (TW)
- Meiho University (TW)
Publication Details
- Journal
- Nutrition and Diabetes
- Published
- 2025-08-19
- DOI
- https://doi.org/10.1038/s41387-025-00388-5
- Citations
- 2
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Ministry of Education
- Ministry of Education, India
- Ministry of Science and Technology, Taiwan